Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00064818 · ClinicalTrials.gov registry record

Acupuncture Needling on Connective Tissue by Ultrasound

A clinical trial, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
46
Enrollment target

NCT00064818: Completed study, sponsored by National Center for Complementary and Integrative Health (NCCIH).

NCT00064818 is a clinical trial that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00064818 has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
46 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effect of acupuncture needling on connective tissue using ultrasound techniques both in animals and in humans.

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2000-09
Est. Completion 2003-09

What the finished NCT00064818 record still lists

NCT00064818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00064818 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00064818 about?

NCT00064818 is a clinical study titled "Acupuncture Needling on Connective Tissue by Ultrasound". The purpose of this study is to investigate the effect of acupuncture needling on connective tissue using ultrasound techniques both in animals and in humans.

What is the current status of trial NCT00064818?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2000-09. Estimated completion is 2003-09.

Who is sponsoring clinical trial NCT00064818?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00064818, the US trial registry maintained by the National Library of Medicine. NCT00064818 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.